Affordable Access

Publisher Website

Aspirin and stroke prevention

Authors
Journal
Thrombosis Research
0049-3848
Publisher
Elsevier
Publication Date
Volume
110
Identifiers
DOI: 10.1016/s0049-3848(03)00414-6
Keywords
  • Aspirin
  • Stroke
  • Arterial Disease
Disciplines
  • Biology
  • Medicine

Abstract

Abstract According to meta-analyses aspirin provides a relative reduction in the rate of major vascular events of 19% in patients with arterial disease in general, whereas for patients with ischaemic cerebrovascular disease this reduction is only 13%. The discrepancy may well result from pathophysiological differences and not from a play of chance. There is no proven difference in efficacy according to dose. The evidence for this equivalence is most compelling in the range between 75 and 1300 mg daily, but still fairly convincing for doses between 30 and 50 mg. In contrast, side effects are clearly more frequent as the dose is higher. Other antiplatelet agents (sulfinpyrazone, ticlopidine, clopidogrel, dipyridamole, orally administered IIb/IIIa inhibitors) have no clear advantages over aspirin and in some cases definite disadvantages; the combination of aspirin and dipyridamole may be more efficacious than aspirin alone, but the evidence hinges on a single trial. If recurrent TIAs occur under treatment with aspirin, the rational response is not to change to a different antiplatelet agent, but to review the diagnosis and consider causes other than artery-to-artery embolism. Platelet aggregation can probably still occur despite complete acetylation of platelets, via pathways other than COX-1 inhibition, but in vitro aggregation tests are an unreliable measure.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Aspirin in the prevention of strokes.

on Biomedicine & Pharmacotherapy August 1999

Aspirin in the prevention of strokes

on Biomedicine & Pharmacotherapy Jan 01, 1999

Aspirin and stroke prevention.

on The Lancet Jan 23, 1988

Aspirin in stroke prevention.

on Journal of stroke and cerebrov... 1991
More articles like this..